XSHE
002162
Market cap581mUSD
Oct 09, Last price
4.41CNY
1D
4.26%
1Q
22.84%
IPO
-38.42%
Name
Shanghai Everjoy Health Group Co Ltd
Chart & performance
P/E
602.92
P/S
3.82
EPS
0.01
Div yield, %
—
Shrs. gr., 5y
-0.66%
Rev. gr., 5y
-3.38%
Revenues
1.06b
-11.82%
Net income
7m
P
CFO
74m
-9.95%
Dividend
May 26, 20110.05 CNY/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Everjoy Health Group Co., Ltd. is primarily involved in the complete lifecycle of ceramic tiles within China, encompassing their conceptualization, manufacturing, and market distribution. Additionally, the firm diversifies its portfolio by offering medical and retirement care provisions. It further engages in the acquisition and rental of real estate assets. The company's origins trace back to 1993, with its operational headquarters situated in Shanghai, China.
Key people
Cixiong Li
Chairman of the Board · since 2017
Qixin Wang
President, Director · since 2017
Tailong Xu
Finance Director, Vice President · since 2017
Kejian Chen
Vice Chairman of the Board, Executive Vice President · since 2013
Weixin Gao
Director · since 2011
Independent Director · since 2008
Zongzhi Jin
Independent Director · since 2009
Independent Director · since 2011
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2023‑00 | 2022‑12 | 2022‑00 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||||
Revenues | ||||||||||||
Cost of revenue | ||||||||||||
Unusual Expense (Income) | ||||||||||||
NOPBT | ||||||||||||
NOPBT Margin | ||||||||||||
Operating Taxes | ||||||||||||
Tax Rate | ||||||||||||
NOPAT | ||||||||||||
Net income | ||||||||||||
Dividends | ||||||||||||
Dividend yield | ||||||||||||
Proceeds from repurchase of equity | ||||||||||||
BB yield | ||||||||||||
| Debt | ||||||||||||
Debt current | ||||||||||||
Long-term debt | ||||||||||||
Deferred revenue | ||||||||||||
Other long-term liabilities | ||||||||||||
Net debt | ||||||||||||
| Cash flow | ||||||||||||
Cash from operating activities | ||||||||||||
CAPEX | ||||||||||||
Cash from investing activities | ||||||||||||
Cash from financing activities | ||||||||||||
FCF | ||||||||||||
| Balance | ||||||||||||
Cash | ||||||||||||
Long term investments | ||||||||||||
Excess cash | ||||||||||||
Stockholders' equity | ||||||||||||
Invested Capital | ||||||||||||
ROIC | ||||||||||||
ROCE | ||||||||||||
| EV | ||||||||||||
Common stock shares outstanding | ||||||||||||
Price | ||||||||||||
Market cap | ||||||||||||
EV | ||||||||||||
EBITDA | ||||||||||||
EV/EBITDA | ||||||||||||
Interest | ||||||||||||
Interest/NOPBT | ||||||||||||